Showing results (51-60 of 752) with videos related to

Sort By:
Pageof 76
Current Cardiology Reports|February 25, 2012
EvacetrapibStephen J Nicholls
Current Cardiology Reports|March 5, 2019
The New Face of Hyperlipidemia and the Role of PCSK9 InhibitorsStephen J Nicholls
Kardiologia Polska|February 5, 2023
PCSK9 inhibitors and reduction in cardiovascular events: Current evidence and future perspectivesStephen J Nicholls
European Cardiology|October 13, 2018
Management of Severe Dyslipidaemia: Role of PCSK9 InhibitorsStephen J Nicholls
The American Journal of Cardiology|November 10, 2009
High-density lipoprotein and progression rate of atherosclerosis in intravascular ultrasound trialsStephen J Nicholls
International Journal of Molecular Sciences|August 26, 2022
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B LevelsAdam J Nelson, Allan D Sniderman, Marc Ditmarsch, et al.
European Stroke Journal|February 15, 2024
Asymptomatic coronary artery disease in ischaemic stroke survivors: A systematic review and meta-analysisRahul G Muthalaly, Timothy B Abrahams, Nitesh Nerlekar, et al.
European Heart Journal|May 25, 2026
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trialsStephen J Nicholls, Adam J Nelson, Kausik K Ray, et al.
JBI Evidence Synthesis|September 3, 2024
Effectiveness of receiving cardiovascular disease genetic risk information on health behaviors, psychological responses, and associated risk factor modification in individuals: a systematic review protocolRuofei Trophy Chen, Vincent Pearson, Orathai Suebkinorn, et al.
Atherosclerosis|February 28, 2025
Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENSMasashi Fujino, Giuseppe Di Giovanni, Julie Butters Bhsc, et al.
Pageof 76